218 related articles for article (PubMed ID: 2310281)
1. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring.
Tajiri J; Noguchi S; Murakami T; Murakami N
Arch Intern Med; 1990 Mar; 150(3):621-4. PubMed ID: 2310281
[TBL] [Abstract][Full Text] [Related]
2. [Studies on onset patterns in antithyroid drug-induced agranulocytosis].
Tajiri J; Noguchi S; Morita M; Tamaru M; Murakami N
Nihon Naibunpi Gakkai Zasshi; 1993 May; 69(5):530-3. PubMed ID: 7687222
[TBL] [Abstract][Full Text] [Related]
3. [Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs].
Dai W; Zhang J; Zhan Z; Xu B; Jin H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):226-9. PubMed ID: 11367711
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of granulocyte count measurement four hours after injection of granulocyte colony-stimulating factor for detecting recovery from antithyroid drug-induced granulocytopenia.
Tajiri J; Noguchi S; Murakami N
Thyroid; 1997 Aug; 7(4):575-8. PubMed ID: 9292945
[TBL] [Abstract][Full Text] [Related]
5. [Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis].
Tajiri J; Noguchi S; Morita M; Tamaru M; Murakami N
Nihon Naibunpi Gakkai Zasshi; 1993 Oct; 69(9):1013-6. PubMed ID: 7505241
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis.
Dai WX; Zhang JD; Zhan SW; Xu BZ; Jin H; Yao Y; Xin WC; Bai Y
Endocr J; 2002 Feb; 49(1):29-33. PubMed ID: 12008747
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment.
Kobayashi S; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Ohye H; Suzuki M; Yoshihara A; Iwaku K; Sugino K; Ito K
Thyroid; 2014 May; 24(5):796-801. PubMed ID: 24341564
[TBL] [Abstract][Full Text] [Related]
8. Methimazole-induced agranulocytosis preceded by transient granulocytopenia. A case report.
Schut NH; Wiersinga WM; Van Oers MH
Neth J Med; 1993 Aug; 43(1-2):71-3. PubMed ID: 8232698
[TBL] [Abstract][Full Text] [Related]
9. Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis.
Tajiri J; Noguchi S
Thyroid; 2004 Jun; 14(6):459-62. PubMed ID: 15242574
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia.
Tajiri J; Noguchi S; Okamura S; Morita M; Tamaru M; Murakami N; Niho Y
Arch Intern Med; 1993 Feb; 153(4):509-14. PubMed ID: 7679571
[TBL] [Abstract][Full Text] [Related]
11. Morning granulocytopenia in a case of Graves' disease.
Nakamura S; Isaji M; Ishimori M
Endocr J; 2001 Apr; 48(2):181-4. PubMed ID: 11456265
[TBL] [Abstract][Full Text] [Related]
12. Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan.
Nakamura H; Miyauchi A; Miyawaki N; Imagawa J
J Clin Endocrinol Metab; 2013 Dec; 98(12):4776-83. PubMed ID: 24057289
[TBL] [Abstract][Full Text] [Related]
13. Delayed anithyroid drug-induced agranulocytosis.
Mutharasan P; Oatis W; Kwaan H; Molitch M
Endocr Pract; 2012; 18(4):e69-72. PubMed ID: 22297058
[TBL] [Abstract][Full Text] [Related]
14. Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF).
Magner JA; Snyder DK
Thyroid; 1994; 4(3):295-6. PubMed ID: 7530522
[TBL] [Abstract][Full Text] [Related]
15. Immunological: reactions involving leukocytes: III. Agranulocytosis induced by antithyroid drugs.
Bilezikian SB; Laleli Y; Tsan MF; Hodkinson BA; Ice S; McIntyre PA
Johns Hopkins Med J; 1976 Apr; 138(4):124-9. PubMed ID: 58084
[TBL] [Abstract][Full Text] [Related]
16. Propylthiouracil (PTU)-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF).
Balkin MS; Buchholtz M; Ortiz J; Green AJ
Thyroid; 1993; 3(4):305-9. PubMed ID: 7509672
[TBL] [Abstract][Full Text] [Related]
17. Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease.
Watanabe N; Narimatsu H; Noh JY; Yamaguchi T; Kobayashi K; Kami M; Kunii Y; Mukasa K; Ito K; Ito K
J Clin Endocrinol Metab; 2012 Jan; 97(1):E49-53. PubMed ID: 22049174
[TBL] [Abstract][Full Text] [Related]
18. Adverse effects related to antithyroid drugs and their dose regimen.
Romaldini JH; Werner MC; Bromberg N; Werner RS
Exp Clin Endocrinol; 1991 May; 97(2-3):261-4. PubMed ID: 1915643
[No Abstract] [Full Text] [Related]
19. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily.
Takata K; Kubota S; Fukata S; Kudo T; Nishihara E; Ito M; Amino N; Miyauchi A
Thyroid; 2009 Jun; 19(6):559-63. PubMed ID: 19445623
[TBL] [Abstract][Full Text] [Related]
20. Emphasis on the early diagnosis of antithyroid drug-induced agranulocytosis: retrospective analysis over 16 years at one Chinese center.
He Y; Li J; Zheng J; Khan Z; Qiang W; Gao F; Zhao Y; Shi B
J Endocrinol Invest; 2017 Jul; 40(7):733-740. PubMed ID: 28236218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
